Merger Agreement for Astellas Pharma Inc and iota Biosciences
Astellas Pharma Inc. and iota Biosciences, Inc. have announced that Astellas, through a U.S. subsidiary, and iota have entered into a Merger Agreement, with...
Merger announced between RBW Consulting and Thorp Associates, with new Chief Growth Officer
A merger has been announced between RBW Consulting, specialist life science and technology search consultancy, and Thorp Associates, executive search and selection company. Emma Thorp,...
AbbVie to acquire Allergan in “transformative move”
Abbvie to acquire Allergan after entering into a definitive transaction agreement under which AbbVie will acquire the company in a cash and stock transaction...
Novartis acquires IFM Tre
Novartis will add to its broad portfolio of immunomodulatory medicines with the planned acquisition of IFM Tre, a subsidiary of IFM Therapeutics LLC focused...
GHO Capital acquires Sterling Pharma Solutions
European specialist investor in healthcare, GHO Capital, has acquired a majority stake in Sterling Pharma Solutions, a specialist in complex and difficult to manufacture...
Healthtech M&A and IPO Activity
The latest Healthtech M&A and IPO Activity Market Report from Hampleton Partners has revealed a final count of almost 100 deals in the healthtech...
DoseCare acquires Biodose
DoseCare announces its acquisition of Biodose, the UK’s only monitored dosage system (MDS) that accommodates liquid and solid medication. Biodose, a medication management solution,...
UK pharma pressing ahead with M&As in 2019
The UK pharmaceutical industry is pressing ahead with M&A activity and is geared to weather any disruption due to Brexit, according to the results...
Sanofi and Denali join forces on inflammatory disease drugs
Sanofi plans to collaborate with Denali Therapeutics Inc. on the development of multiple molecules with the potential to be neurological and systemic inflammatory disease...
AstraZeneca divests rights for Nexium and Vimovo to Grünenthal
AstraZeneca has agreed to divest the prescription medicine rights for Nexium in Europe, as well as the global rights (excluding the US and Japan)...
Latest articles
Virtual clinical trial recruits 67% faster led by NIHR Patient Recruitment Centre
A collaboration between one of the NIHR’s new National Patient Recruitment Centres (NPRCs) and UK sponsor company Enteromed has led to rapid recruitment to...
Cost of Russian Sputnik V vaccine for international markets to be less than $10...
The cost of the Russian Sputnik V vaccine for international markets will be less than $10 per dose starting from February 2021, making it...
R&D spending in the UK pharmaceutical sector has jumped 6.9% annually
Analysis of the latest ONS data by R&D tax relief specialists Catax shows that R&D spending in the UK pharmaceutical sector has jumped 6.9%...
Popular articles
New Normal, New Thinking: Life Post COVID-19
New thinking will be required to adapt to the new normal life post COVID-19. I hate to start this article on a negative note, but...
Understanding the role of the MSL
Helen Kane surveyed more than 200 medical science liaisons (MSLs) to understand more about their current in-role reality. She gave Pf Magazine exclusive access...
Virtual clinical trial recruits 67% faster led by NIHR Patient Recruitment Centre
A collaboration between one of the NIHR’s new National Patient Recruitment Centres (NPRCs) and UK sponsor company Enteromed has led to rapid recruitment to...
Top 5 R&D hubs in the UK
Read this cover story in the June issue of Pf Magazine here. Join us on a tour of inspirational research and development centres. ...
Pancreatic Cancer Story: James Dadge
James, 44, lives in Manchester with his partner Andrea and sons Ben and Daniel. He was diagnosed with a neuroendocrine tumour, with the primary...